MedTrace Logo

Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases

NCT02615665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2015-11-26

No results posted yet for this study

Summary

The long-term outcome of patients resected for colorectal liver metastases (CLM) after neoadjuvant chemotherapy (CHT) depends by several tumoral and non-tumoral factors, such as the immune response to the tumor and to the CHT. The aim of this study was to investigate the impact of the pathological and immunological response in patients undergoing liver resection for CLM after CHT in regards to the long-term outcome.

Conditions

  • Colorectal Liver Metastases

Interventions

PROCEDURE

Hepatic resection

Removal of a part of the liver during surgery

Sponsors & Collaborators

  • University of Milan

    lead OTHER

Principal Investigators

  • Guido Torzilli, MD, PhD · Humanitas University, Humanitas Research Hospital IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02615665 on ClinicalTrials.gov